Aimia Inc. (TSX:AIM)
Canada
· Delayed Price · Currency is CAD | Market Cap | 262.41M |
| Revenue (ttm) | 502.50M |
| Net Income (ttm) | -1.10M |
| Shares Out | 89.26M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | 14.70 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 19,075 |
| Average Volume | 73,595 |
| Open | 3.000 |
| Previous Close | 2.960 |
| Day's Range | 2.940 - 3.000 |
| 52-Week Range | 2.270 - 3.440 |
| Beta | 0.08 |
| RSI | 42.98 |
| Earnings Date | Mar 24, 2026 |
About Aimia
Aimia Inc. invests in public and private companies. It operates in three segments: Bozzetto, Cortland International, and Holdings. The company, through its long-term investments, provides specialty chemicals, textiles, and water and dispersion chemical solutions in various applications, including textile, home and personal care, plasterboard, and agrochemical markets; manufactures synthetic fiber ropes, as well as offers netting solutions for maritime and other industrial customers; and manufactures and supplies ropes, slings, and tethers for a... [Read more]
Financial Performance
In 2024, Aimia's revenue was 487.10 million, an increase of 134.52% compared to the previous year's 207.70 million. Losses were -71.10 million, -64.56% less than in 2023.
Financial StatementsNews
Verdict parent company GlobalData moves to Main Market of LSE
The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term strategy. The post Verdict parent company GlobalData moves to Main Market of LSE ...
AIM Collaborates with Thermo Fisher for Phase 3 Trial of Ampligen in Pancreatic Cancer
AIM Collaborates with Thermo Fisher for Phase 3 Trial of Ampligen in Pancreatic Cancer
AIMIA PROVIDES UPDATE ON ITS SHARE BUYBACKS
TORONTO , March 2, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) announced that it repurchased and settled for cancellation a total of 107,800 of its common shares in the month of February 2026 under...
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer
OCALA, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced milestones in the expected timeline for the ongoing Phase 2 clinical study eval...
Aimia Inc. (AIM:CA) Aimia Inc., Giovanni Bozzetto S.p.A., - M&A Call - Slideshow
2026-02-18. The following slide deck was published by Aimia Inc.
AIMIA ANNOUNCES DUAL LISTING ON JOHANNESBURG STOCK EXCHANGE
TORONTO , Feb. 17, 2026 /CNW/ - Aimia Inc. (TSX: AIM) ("the Company") announced today the dual listing of its common shares on the Main Board of the Johannesburg Stock Exchange (" JSE ") effective Fe...
IHG revenues up, ITM Power upgrades outlook and Debenhams funding round
Plus we have updates from AIM listed Helium One and Cambridge Cognition - and we turn our attention to German stocks for our Plus+ members
Aimia Inc. (AIM:CA) M&A Call Transcript
Aimia Inc. (AIM:CA) M&A Call Transcript
Aimia To Sell Its Stake In Giovanni Bozzetto To One Equity Partners
(RTTNews) - Aimia Inc. (AIM.TO), Monday announced an agreement agreement to sell its interest in Giovanni Bozzetto S.p.A, a specialty chemicals business, to One Equity Partners for a purchase price in...
Aimia Inc. (AIM:CA) Q3 2025 Earnings Call Transcript
Aimia Inc. ( AIM:CA) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Joseph Racanelli - Vice President of Investor Relations & Communications Rhys Summerton - Executive Chair...
Aimia Inc. (AIMFF) Q2 2025 Earnings Call Transcript
Aimia Inc. (AIMFF) Q2 2025 Earnings Call Transcript
Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Rhys Summerton - Executive Chairman Steven L...
Aimia Inc. (AIMFF) Q4 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q4 2024 Results Conference Call March 28, 2025 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Tom Finke - Executive Chairman Rhys Summert...
Aimia Inc. (AIMFF) Q3 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Tom Finke - Executive Chairman Steve Leo...
Aimia Inc. (AIMFF) Q2 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Joe Racanelli - Investor Relations Tom Finke - Executive Chairman Steve Leonard - President & ...
Aimia Inc. (AIMFF) Q1 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Joe Racanelli - VP, IR and Communications Tom Finke - Executive Chairman Steve Leonard - Chief Fin...
Aimia Inc. (AIMFF) Q4 2023 Earnings Call Transcript
Aimia Inc. (AIMFF) Q4 2023 Earnings Call Transcript
Aimia, Inc. (AIMFF) Q3 2023 Earnings Call Transcript
Aimia, Inc. (OTCPK:AIMFF) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Albert Matousek - IR Phil Mittleman - CEO Michael Lehmann - President Steve Leonard - CFO C...
Aimia Inc. (AIMFF) Q2 2023 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ET Company Participants Albert Matousek - Head of Investor Relations and Communications Phil Mittleman - Chief Executi...
Aimia (AIMFF) Q4 2022 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Phil Mittleman - Chief Executive Officer Michael Lehman - President Steven Leonard - Chief Fina...
Aimia: Trading Close To Net Cash + Marketable Securities With M&A Optionality
Aimia is trading approximately around its net cash plus marketable securities value. Applying punitive discounts to its private investments, Aimia's NAVPS is roughly 30% above where the stock is tradi...
Aimia, Inc. (AIMFF) Q3 2022 Earnings Call Transcript
Aimia, Inc. (OTCPK:AIMFF) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ET Company Participants Albert Matousek - Head, IR & Communications Phil Mittleman - CEO Michael Lehmann - President...
Aimia, Inc. (AIMFF) CEO Philip Mittleman on Q2 2022 Results - Earnings Call Transcript
Aimia, Inc. (OTCPK:AIMFF) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Steven Leonard - CFO Philip Mittleman - CEO & Director Michael Lehmann - President & Director...
Aimia Is Swimming in Cash
The sale of Aimia Inc.'s ( TSX:AIM , Financial) ( AIMFF , Financial) stake in Air Mexico's loyalty program Club Premier will be a huge liquidity event for this Toronto-based asset manager. In fact, fo...
Aimia's (AIMFF) CEO Phil Mittleman on Q1 2022 Results - Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Tom Tran – Head-Investor Relations Phil Mittleman – Chief Executive Officer Michael Lehmann – Pres...